Literature DB >> 27967217

Diet Polyphenol Curcumin Stimulates Hepatic Fgf21 Production and Restores Its Sensitivity in High-Fat-Diet-Fed Male Mice.

Kejing Zeng1,2, Lili Tian2,3, Rucha Patel4, Weijuan Shao2, Zhuolun Song2,3, Ling Liu2, Justin Manuel5, Xuezhong Ma5, Ian McGilvray5, Carolyn L Cummins3,4, Jianping Weng, Tianru Jin2,3,6,7.   

Abstract

We found previously that short-term curcumin gavage stimulated mouse hepatic fibroblast growth factor 21 (Fgf21) expression. Here we conducted mechanistic exploration and investigated the potential pathophysiological relevance on this regulation. Fgf21 stimulation was observed at messenger RNA and protein levels in mice with daily curcumin gavage for 4 or 8 days and in primary hepatocytes with curcumin treatment. Using peroxisome proliferator-activated receptor α (PPARα) agonist and antagonist, along with luciferase reporter and chromatin immune-precipitation approaches, we determined that curcumin stimulates Fgf21 transcription in a mechanism involving PPARα activation. High-fat diet (HFD) feeding also increased mouse hepatic and serum Fgf21 levels, whereas dietary curcumin intervention attenuated these increases. We found that HFD feeding reduced hepatic expression levels of genes that encode FGFR1 and βKlotho, PGC1α, and the targets of the PPARα-PGC1α axis, whereas concomitant curcumin intervention restored or partially restored their expression levels. Importantly, hepatocytes from HFD-fed mice showed a loss of response to FGF21 treatment on Erk phosphorylation and the expression of Egr1 and cFos; this response was restored in hepatocytes from HFD-fed mice with curcumin intervention. This investigation expanded our mechanistic understanding of the metabolic beneficial effects of dietary curcumin intervention involving the regulation of Fgf21 production and the attenuation of HFD-induced Fgf21 resistance.
Copyright © 2017 by the Endocrine Society.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27967217     DOI: 10.1210/en.2016-1596

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  19 in total

1.  Dietary Cyanidin-3-Glucoside Attenuates High-Fat-Diet-Induced Body-Weight Gain and Impairment of Glucose Tolerance in Mice via Effects on the Hepatic Hormone FGF21.

Authors:  Lili Tian; Hongmei Ning; Weijuan Shao; Zhuolun Song; Yasaman Badakhshi; Wenhua Ling; Burton B Yang; Patricia L Brubaker; Tianru Jin
Journal:  J Nutr       Date:  2020-08-01       Impact factor: 4.798

Review 2.  Therapy to Obese Type 2 Diabetes Mellitus: How Far Will We Go Down the Wrong Road?

Authors:  Xian-Pei Heng; Xiu-Jun Li; Liang Li; Liu-Qing Yang; Zi-Ta Wang; Su-Ping Huang
Journal:  Chin J Integr Med       Date:  2018-10-17       Impact factor: 1.978

Review 3.  Curcumin and dietary polyphenol research: beyond drug discovery.

Authors:  Tian-Ru Jin
Journal:  Acta Pharmacol Sin       Date:  2018-03-15       Impact factor: 6.150

Review 4.  The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic.

Authors:  Leiluo Geng; Karen S L Lam; Aimin Xu
Journal:  Nat Rev Endocrinol       Date:  2020-08-06       Impact factor: 43.330

5.  Pak1 mediates the stimulatory effect of insulin and curcumin on hepatic ChREBP expression.

Authors:  Kejing Zeng; Lili Tian; Adam Sirek; Weijuan Shao; Ling Liu; Yu-Ting Chiang; Jonathan Chernoff; Dominic S Ng; Jianping Weng; Tianru Jin
Journal:  J Mol Cell Biol       Date:  2017-10-01       Impact factor: 6.216

6.  Fibroblast activation protein is dispensable for control of glucose homeostasis and body weight in mice.

Authors:  Brandon L Panaro; Andrew L Coppage; Jacqueline L Beaudry; Elodie M Varin; Kirandeep Kaur; Jack H Lai; Wengen Wu; Yuxin Liu; William W Bachovchin; Daniel J Drucker
Journal:  Mol Metab       Date:  2018-11-05       Impact factor: 7.422

7.  Novel Combinatorial Regimen of Garcinol and Curcuminoids for Non-alcoholic Steatohepatitis (NASH) in Mice.

Authors:  Muhammed Majeed; Shaheen Majeed; Kalyanam Nagabhushanam; Lincy Lawrence; Lakshmi Mundkur
Journal:  Sci Rep       Date:  2020-05-04       Impact factor: 4.379

8.  Curcumin promotes AApoAII amyloidosis and peroxisome proliferation in mice by activating the PPARα signaling pathway.

Authors:  Jian Dai; Ying Li; Fuyuki Kametani; Xiaoran Cui; Yuichi Igarashi; Jia Huo; Hiroki Miyahara; Masayuki Mori; Keiichi Higuchi
Journal:  Elife       Date:  2021-01-26       Impact factor: 8.140

9.  Curcumin supplementation mitigates NASH development and progression in female Wistar rats.

Authors:  Rory P Cunningham; Mary P Moore; Angelique N Moore; James C Healy; Michael D Roberts; R Scott Rector; Jeffrey S Martin
Journal:  Physiol Rep       Date:  2018-07

Review 10.  Antidiabetic Properties of Curcumin I: Evidence from In Vitro Studies.

Authors:  Danja J Den Hartogh; Alessandra Gabriel; Evangelia Tsiani
Journal:  Nutrients       Date:  2020-01-01       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.